Literature DB >> 24726082

A review of the current epidemiology and treatment options for prostate cancer.

Daniel M Saman, Andrine M Lemieux, May Nawal Lutfiyya, Martin S Lipsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24726082     DOI： 10.1016/j.disamonth.2014.02.003

Source DB:  PubMed          Journal:  Dis Mon        ISSN： 0011-5029            Impact factor:   3.800


× No keyword cloud information.
  7 in total

Review 1.  Molecular mechanisms of curcumin and its semisynthetic analogues in prostate cancer prevention and treatment.

Authors:  Brian C Jordan; Charlotta D Mock; Ramasamy Thilagavathi; Chelliah Selvam
Journal:  Life Sci       Date:  2016-03-24       Impact factor: 5.037

2.  A pilot study assessing the association between paraoxonase 1 gene polymorphism and prostate cancer.

Authors:  Nihat Uluocak; Doğan Atılgan; Bekir Süha Parlaktaş; Fikret Erdemir; Ömer Ateş
Journal:  Turk J Urol       Date:  2017-07-31

Review 3.  Computer-aided Detection of Prostate Cancer with MRI: Technology and Applications.

Authors:  Lizhi Liu; Zhiqiang Tian; Zhenfeng Zhang; Baowei Fei
Journal:  Acad Radiol       Date:  2016-04-25       Impact factor: 3.173

4.  Advanced impedimetric biosensor configuration and assay protocol for glycoprofiling of a prostate oncomarker using Au nanoshells with a magnetic core.

Authors:  Tomas Bertok; Lenka Lorencova; Stefania Hroncekova; Veronika Gajdosova; Eduard Jane; Michal Hires; Peter Kasak; Ondrej Kaman; Roman Sokol; Vladimir Bella; Anita Andicsova Eckstein; Jaroslav Mosnacek; Alica Vikartovska; Jan Tkac
Journal:  Biosens Bioelectron       Date:  2019-02-01       Impact factor: 12.545

5.  Isoform switch of pyruvate kinase M1 indeed occurs but not to pyruvate kinase M2 in human tumorigenesis.

Authors:  Cheng Zhan; Li Yan; Lin Wang; Jun Ma; Wei Jiang; Yongxing Zhang; Yu Shi; Qun Wang
Journal:  PLoS One       Date:  2015-03-04       Impact factor: 3.240

6.  Integrated multimodal imaging of dynamic bone-tumor alterations associated with metastatic prostate cancer.

Authors:  Jean-Christophe Brisset; Benjamin A Hoff; Thomas L Chenevert; Jon A Jacobson; Jennifer L Boes; Stefanie Galbán; Alnawaz Rehemtulla; Timothy D Johnson; Kenneth J Pienta; Craig J Galbán; Charles R Meyer; Timothy Schakel; Klaas Nicolay; Ajjai S Alva; Maha Hussain; Brian D Ross
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

7.  Regression of prostate tumors after intravenous administration of lactoferrin-bearing polypropylenimine dendriplexes encoding TNF-α, TRAIL, and interleukin-12.

Authors:  Najla Altwaijry; Sukrut Somani; John A Parkinson; Rothwelle J Tate; Patricia Keating; Monika Warzecha; Graeme R Mackenzie; Hing Y Leung; Christine Dufès
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.